(81 days)
Not Found
No
The summary describes a modification to the manufacturing process of a polyethylene component for hip implants. There is no mention of software, algorithms, image processing, or any terms related to AI/ML.
Yes.
The device is indicated for various medical conditions such as degenerative joint disease, rheumatoid arthritis, correction of functional deformity, and revision of failed total hip arthroplasty, all of which aim to treat or alleviate a disease or injury.
No
The device is described as a modification to components used in total hip arthroplasty (joint replacement surgery), specifically polyethylene acetabular liners. Its intended uses (e.g., non-inflammatory degenerative joint disease, rheumatoid arthritis, correction of functional deformity/fracture, revision of previously failed arthroplasty) are all related to treatment or repair, not diagnosis.
No
The device description clearly states it is a modification to the manufacturing process of ultrahigh molecular weight polyethylene (UHMWPE) used in the fabrication of physical components (acetabular liners), indicating it is a hardware device, not software.
No, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- IVD Definition: In Vitro Diagnostics are medical devices used to examine specimens taken from the human body (like blood, urine, or tissue) to provide information about a person's health. They are used outside of the body.
- Device Description: The description clearly states this device is a "polyethylene acetabular liner" used in "total hip arthroplasty." This is an implantable device used inside the body during surgery.
- Intended Use: The intended uses listed are all related to treating conditions of the hip joint through surgical implantation.
Therefore, based on the provided information, this device is a surgical implant, not an In Vitro Diagnostic.
N/A
Intended Use / Indications for Use
-
- Non-inflammatory degenerative joint disease including osteoarthritis and avascular necrosis.
-
- Rheumatoid arthritis.
-
- Correction of functional deformity.
-
- Correction of functional deck fracture, and trochanteric fractures of the proximal femur with head involvement, unmanageable using other techniques.
-
- Revision of previously failed total hip arthroplasty.
Cemented and Uncemented Applications
- Revision of previously failed total hip arthroplasty.
Product codes
JDI, LWJ, LPH, MAY
Device Description
Biomet Manufacturing Corp. is modifying the manufacturing process of ultrahigh molecular weight polyethylene (UHMWPE) used in the fabrication of polyethylene acetabular mgh molecular naglio partiles. The modified manufacturing process results in a higher cross-linked polyethylene. The highly cross-linked UHMWPE is infused with medical grade Vitamin E.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
Hip
Indicated Patient Age Range
Not Found
Intended User / Care Setting
Not Found
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
Non-Clinical Testing: Non-clinical laboratory testing was performed to determine substantial equivalence. The results indicated that the device was functional within its intended use.
Clinical Testing: None provided as a basis for substantial equivalence.
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s)
K050327- E-Poly™ (Vitamin E) Acetabular Liners
Reference Device(s)
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information
Not Found
§ 888.3350 Hip joint metal/polymer semi-constrained cemented prosthesis.
(a)
Identification. A hip joint metal/polymer semi-constrained cemented prosthesis is a device intended to be implanted to replace a hip joint. The device limits translation and rotation in one or more planes via the geometry of its articulating surfaces. It has no linkage across-the-joint. This generic type of device includes prostheses that have a femoral component made of alloys, such as cobalt-chromium-molybdenum, and an acetabular resurfacing component made of ultra-high molecular weight polyethylene and is limited to those prostheses intended for use with bone cement (§ 888.3027).(b)
Classification. Class II.
0
K070399 page '1 of
Image /page/0/Picture/1 description: The image shows the word "BIOMET" in a stylized, blocky font. The letters are outlined in black, with a white fill. The font is bold and sans-serif, giving the word a strong and modern appearance.
510(k) Summary
February 9, 2007 Preparation Date:
MAY - 4 2007
Biomet Manufacturing Corp. Applicant/Sponsor:
Contact Person: Tracy Bickel Johnson, RAC
Proprietary Name: 100 kGy E-Poly™Acetabular Liners- Additional Profiles
Common Name: UHMWPE Liners
Classification Name(s):
- LPH- prosthesis, hip, semi-constrained, metal/polymer, porous uncemented (888.3358); .
- JDI- prosthesis, hip, semi-constrained, metal/polymer, cemented (888.3350); .
- LWJ- prosthesis, hip, semi-constrained, metal/polymer, uncemented (888.3360); .
- MAY prosthesis, hip, semi-constrained, metal/ceramic/polymer, cemented or non-porous cemented, osteophilic finish (888.3353)
- LZO- prosthesis, hip, semi-constrained, metal/ceramic/polymer, cemented or non-porous, . uncemented (888.3353)
Legally Marketed Devices To Which Substantial Equivalence Is Claimed: K050327- E-
Poly™ (Vitamin E) Acetabular Liners
Device Description: Biomet Manufacturing Corp. is modifying the manufacturing process of ultrahigh molecular weight polyethylene (UHMWPE) used in the fabrication of polyethylene acetabular mgh molecular naglio partiles. The modified manufacturing process results in a higher cross-linked polyethylene. The highly cross-linked UHMWPE is infused with medical grade Vitamin E.
Intended Use:
-
- Non-inflammatory degenerative joint disease including osteoarthritis and avascular necrosis.
-
- Rheumatoid arthritis.
- Correction of functional deformity. 3.
- Treatment of non-union, femoral neck fracture, and trochanteric fractures of the র্ব proximal femur with head involvement, unmanageable using other techniques.
-
- Revision of previously failed total hip arthroplasty.
Cemented and Uncemented Applications
Summary of Technologies: The intended use, indications, contraindications, and design specifications of the subject components remain identical to its predicate counterpart, with the exception of a manufacturing change. The raw material being utilized in the manufacture of both the subject and the predicate devices remains a ultra-high molecular weight polyethylene (UHMWPE) per ASTM F-648. The modifications to the manufacturing process of this polyethylene will be introduced in order to create a higher cross-linked polyethylene. The safety and effectiveness of this cross-linked polyethylene in acetabular applications are adequately supported by the substantial equivalence information, materials data, and testing results provided within this Premarket Notification.
а маміты. Апана за пастава Status (1991) 1978 (1998) 1999)
and Stitters (1) Marcel Manufacturer (1980)
2 3 4 1 2 4 1
- 2. 3. 4. 5. 6. 7.
a mana a mana ma barbara tanan
1
BIOMET
pg 2/2
510(K) Notification Biomet Manufacturing Corp. 100 kGy E-Poly™ Acetabular Liners- Additional Profiles Page 2 of 2
Non-Clinical Testing: Non-clinical laboratory testing was performed to determine substantial equivalence. The results indicated that the device was functional within its intended use.
Clinical Testing: None provided as a basis for substantial equivalence.
All trademarks are property of Biomet, Inc.
Sun Circuit (1998) Director (1998) (1998) (1998) (1998) (1998) (1998) (1998) (1998) (1998) (1998) (1998) (1998) (1998) (1998) (1998) (1998) (1998) (1998) (1998) (1998) (1998)
AMITNG ADDROSS - Production - Scheminal Annia Marine As
- The Bronding - Children - Charles Ball Ball Ball Bay
- Charles - Charles - Charles - Charles - Walland - Chambia
- C
.
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
2
Public Health Service
Image /page/2/Picture/2 description: The image shows the logo for the Department of Health & Human Services, USA. The logo consists of a circular seal with the text "DEPARTMENT OF HEALTH & HUMAN SERVICES, USA" arranged around the perimeter. Inside the circle is an emblem featuring a stylized eagle with its wings spread, symbolizing the department's mission to protect the health of all Americans.
Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850
Biomet Manufacturing Corp. % Ms. Tracy Bickel Johnson, RAC Manager, Regulatory Affairs P.O. Box 587 Warsaw, Indiana 46581-0587
MAY - 4 2007
Re: K070399
Trade/Device Name: 100kGy E-Poly™ Acetabular Liners – Additional Profiles Regulation Number: 21 CFR 888.3350 Regulation Name: Hip joint metal/polymer semi-constrained cemented prosthesis Regulatory Class: II Product Code: JDI, LWJ, LPH, MAY Dated: April 4, 2007 Received: April 5, 2007
Dear Ms. Johnson:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
3
Page 2 - Ms. Tracy Bickel Johnson, RAC
This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Office of Compliance at (240) 276-0120. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or 240-276-3150 or at its Internet address http://www.fda.gov/cdrh/industry/support/index.html.
Sincerely vours.
Sabare Buchup
fo
Mark N. Melkerson Director Division of General, Restorative and Neurological Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
4
Indications for Use
510(k) Number (if known):
Device Name: 100kGy E-Poly™ Acetabular Components- Additional Profiles Indications For Use:
-
- Non-inflammatory degenerative joint disease including osteoarthritis and avascular necrosis.
-
- Rheumatoid arthritis.
-
- Correction of functional deformity.
-
- Correction of functional deck fracture, and trochanteric fractures of the proximal femur with head involvement, unmanageable using other techniques.
-
- Revision of previously failed total hip arthroplasty.
Cemented and Uncemented Applications
Prescription Use __ YES (Part 21 CFR 801 Subpart D) AND/OR
Over-The-Counter Use_ NO (21 CFR 807 Subpart C)
(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
Chabane Buchun
Division Sign-C Division of General, Restorative, and Neurological Devices
510(k) Number K070399 Page 1 of 1
I - 1